Cover Kidney News
Volume/Issue:
Volume 6: Issue 2
Page:
15
Publication Date:
01 Feb 2014
Online Publication Date:
31 Aug 2015
  • View in gallery

    Acceleron, its partners, and its collaborators have initiated seven phase 2 studies across three of Acceleron’s programs—dalantercept (known first as ACE-041), sotatercept (ACE-011), and ACE-536—since November 2012.

Acceleron, its partners, and its collaborators have initiated seven phase 2 studies across three of Acceleron’s programs—dalantercept (known first as ACE-041), sotatercept (ACE-011), and ACE-536—since November 2012.
Editorial Type:
Industry Spotlight

Acceleron Tests Drugs for Renal Patients

Volume/Issue:
Volume 6: Issue 2
Publication Date:
01 Feb 2014
Page:
15
Restricted access
Save